Methods for obtaining reliable and reproducible results in studies of Candida biofilms formed in vitro

Mycoses

Volumn 56, Issue 6, 2013, Pages 614-622

  Costa, Anna C B P ^a,b   Pereira, Cristiane A ^a   Freire, Fernanda ^a   Junqueira, Juliana C ^a   Jorge, Antonio O C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Biofilm; Candida spp.; Evaluating biofilms; Methods for biofilm formation; Strategies against biofilms

Indexed keywords

3 AMINOPROPYLTRIETHOXYSILANE; ACRYLIC ACID RESIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; CURCUMIN; FARNESOL; MULTIDRUG RESISTANCE PROTEIN 1; POLITEF; POLYURETHAN; POLYVINYLCHLORIDE; PYRROLE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANALYTIC METHOD; ANTIFUNGAL RESISTANCE; BIOFILM; BIOMASS; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; COLONY FORMING UNIT; CONFOCAL LASER MICROSCOPY; DENTURE; DEVICE INFECTION; EXTRACELLULAR MATRIX; FUNGAL GENE; FUNGAL VIRULENCE; IN VITRO STUDY; INVASIVE CANDIDIASIS; KLUYVEROMYCES MARXIANUS; MOUTH HYGIENE; NONHUMAN; OROPHARYNX CANDIDIASIS; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; SCANNING ELECTRON MICROSCOPY; STOMATITIS; THRUSH; YEAST CELL;

CANDIDA;

BIOFILM; CANDIDA SPP.; EVALUATING BIOFILMS; METHODS FOR BIOFILM FORMATION; STRATEGIES AGAINST BIOFILMS;

BIOFILMS; CANDIDA; MICROBIOLOGICAL TECHNIQUES; MYCOLOGY;

EID: 84886297763     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12092     Document Type: Review

References (77)

1. Kuhn DM, Ghannoum MA. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 2004; 5: 186-97.
2. Martinez LR, Casadevall A. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infect Immun 2006; 74: 6118-23.
3. Martinez LR, Casadevall A. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 2006; 50: 1021-33.
4. Mowat E, Butcher J, Lang S et al. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol 2007; 56: 1205-12.
5. Kumamoto CA. Candida biofilms. Curr Opin Microbiol 2002; 5: 608-11.
6. Lopez-Ribot JL. Candida albicans biofilms: more than filamentation. Curr Biol 2005; 15: R453-5.
7. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukaryot Cell 2005; 4: 633-8.
8. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-67.
9. Martinez LR, Fries BC. Fungal biofilms: relevance in the setting of human disease. Curr Fungal Infect Rep 2010; 4: 266-75.
10. El-Azizi MA, Starks SE, Khardori N. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol 2004; 96: 1067-73.
11. Chandra J, Mukherjee PK, Leidich SD et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001; 80: 903-8.
12. Owotade FJ, Shiboski CH, Poole L et al. Prevalence of oral disease among adults with primary HIV infection. Oral Dis 2008; 14: 497-9.
13. Yan Z, Hua H, Xu Y, Samaranayake LP. Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral Candida species and the synergy with fluconazole against azole-resistant Candida albicans. Evid Based Complement Alternat Med 2012; 2012: 106583.
14. Casaroto AR, Lara VS. Phytomedicines for Candida-associated denture stomatitis. Fitoterapia 2010; 81: 323-8.
15. Amanlou M, Beitollahi JM, Abdollahzadeh S, Tohidast-Ekrad Z. Miconazole gel compared with Zataria multiflora Boiss. gel in the treatment of denture stomatitis. Phytother Res 2006; 20: 966-9.
16. Zomorodian K, Haghighi NN, Rajaee N et al. Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers. Med Mycol 2011; 49: 208-11.
17. Salerno C, Pascale M, Contaldo M et al. Candida-associated denture stomatitis. Med Oral Patol Oral Cir Bucal 2011; 16: e139-43.
18. Sabzghabaee AM, Davoodi N, Ebadian B, Aslani A, Ghannadi A. Clinical evaluation of the essential oil of "Satureja Hortensis" for the treatment of denture stomatitis. Dent Res J (Isfahan) 2012; 9: 198-202.
19. Santos VR, Gomes RT, de Mesquita RA et al. Efficacy of Brazilian propolis gel for the management of denture stomatitis: a pilot study. Phytother Res 2008; 22: 1544-7.
20. Uludamar A, Ozkan YK, Kadir T, Ceyhan I. In vivo efficacy of alkaline peroxide tablets and mouthwashes on Candida albicans in patients with denture stomatitis. J Appl Oral Sci 2010; 18: 291-6.
21. Ramage G, Martinez JP, Lopez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006; 6: 979-86.
22. Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000; 19: 1-8.
23. Nobile CJ, Mitchell AP. Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol 2006; 8: 1382-91.
24. Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of Candida: a mini review. Oral Dis 2008; 14: 582-90.
25. Chaffin WL. Candida albicans cell wall proteins. Microbiol Mol Biol Rev 2008; 72: 495-544.
26. ten Cate JM, Klis FM, Pereira-Cenci T, Crielaard W, Groot PWJ. Molecular and cellular mechanisms that lead to Candida biofilm formation. J Dent Res 2009; 88: 105-15.
27. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim Pol 2009; 56: 211-24.
28. Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006; 9: 588-94.
29. Ramage G, Mowat E, Jones B, Willians C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol 2009; 35: 340-55.
30. Lal P, Sharma D, Pruthi P, Pruthi V. Exopolysaccharide analysis of biofilm-forming Candida albicans. J Appl Microbiol 2010; 109: 128-36.
31. Martins M, Uppuluri P, Thomas DP et al. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilm. Mycopathologia 2010; 169: 323-31.
32. Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 2011; 9: 109-18.
33. Bernardo SM, Lee SA. Candida albicans SUR7 contributes to secretion, biofilm formation, and macrophage killing. BMC Microbiol 2010; 10: 133.
34. Hornby JM, Jensen EC, Lisec AD et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 2001; 67: 2982-92.
35. Chen H, Fujita M, Feng Q, Clardy J, Fink GR. Tyrosol is a quorum- sensing molecule in Candida albicans. Proc Natl Acad Sci USA 2004; 101: 5048-52.
36. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol 2009; 54: 1052-60.
37. Costa AC, de Campos Rasteiro VM, Pereira CA et al. Susceptibility of Candida albicans and Candida dubliniensis to erythrosine- and LED- mediated photodynamic therapy. Arch Oral Biol 2011; 56: 1299-305.
38. Parahitiyawa NB, Samaranayake YH, Samaranayake LP et al. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 2009; 114: 298-306.
39. Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol 2009; 47: 681-9.
40. Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol 2009; 4: 1235-7.
41. Ramage G, Tomsett K, Wickes BL, López-Ribot JL, Redding SW. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 53-59.
42. Ribeiro DG, Pavarina AC, Dovigo LN et al. Photodynamic inactivation of microorganisms present on comple denture. A clinical investigation. Photodynamic disinfection of complete dentures. Lasers Med Sci 2012; 27: 161-8.
43. Junqueira JC, Vilela SF, Rossoni RD et al. Oral colonization by yeasts in HIV- positive patients in Brazil. Rev Inst Med Trop Sao Paulo 2012; 54: 17-24.
44. Nailis H, Coenye T, Van Nieuwerburgh F, Deforce D, Nelis HJ. Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real- time PCR. BMC Mol Biol 2006; 4: 7-25.
45. Pereira CA, Romeiro RL, Costa ACBP, Machado AKS, Junqueira JC, Jorge AOC. Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro study. Lasers Med Sci 2011; 26: 341-8.
46. Bujdáková H, Paulovicová E, Paulovicová L, Simová Z. Participation of the Candida albicans surface antigen in adhesion, the first phase of biofilm development. FEMS Immunol Med Microbiol 2010; 59: 485-92.
47. Dovigo LN, Pavarina AC, Mima EGO, Giampaolo ET, Vergani CE, Bagnato VS. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 2011a; 54: 123-30.
48. Junqueira JC, Fuchs BB, Muhammed M et al. Oral Candida albicans isolates from HIV- positive individuals have similar in vitro biofilm- forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol 2011; 11: 247.
49. Estivill D, Arias A, Torres- Lana A, Carrillo- Muñoz AJ, Arévalo MP. Biofilm formation by five species of Candida on three clinical materials. J Microbiol Methods 2011; 86: 238-42.
50. Mukherjee PK, Chandra J. Candida biofilm resistance. Drug Resist Updat 2004; 7: 301-9.
51. Ramage G, Vande Walle K, Wickes BL, López- Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001a; 45: 2475-9.
52. Uppuluri P, Chaturvedi AK, Srinivasan A et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog 2010; 6: e1000828.
53. Taff HT, Nett JE, Andes DR. Comparative analysis of Candida biofilm quantitation assays. Med Mycol 2012; 50: 214-8.
54. Nailis H, Kucharíková S, Ricicová M et al. Real- time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model- dependent and- independent gene expression. BMC Microbiol 2010; 10: 114.
55. Uppuluri P, Lopez-Ribot JL. An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow. Virulence 2010; 1: 483-7.
56. Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm- forming ability of Candida albicans is unlikely to contribute to high levels of oral yeasts carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003; 41: 2961-7.
57. Junqueira JC, Jorge AO, Barbosa JO et al. Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2, 9, 16, 23-tetrakis(phenylthio)-29H, 31H- phthalocyanine (ZnPc). Lasers Med Sci 2012; 27: 1205-12.
58. Harrison JJ, Rabiei M, Turner RJ, Badry EA, Sproule KM, Ceri H. Metal resistance in Candida biofilms. FEMS Microbiol Ecol 2006; 55: 479-91.
59. Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK. Development of a high-throughput Candida albicans biofilm chip. PLoS ONE 2011; 6: e19036.
60. Nobile CJ, Mitchell AP. Regulation of cell- surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 2005; 15: 1150-5.
61. Nett JE, Cain MT, Crawford K, Andes DR. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J Clin Microbiol 2011; 49: 1426-33.
62. Hasan F, Xess I, Wang X, Jain N, Fries BC. Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect 2009; 11: 753-61.
63. Hawser SP, Douglas LJ. Resistence of Candida albicans biofilms to antifungal agents in vitro. Antimicrobial Agents Chemother 1995; 39: 2128-31.
64. Suci PA, Tyler BJ. Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm. Antimicrob Agents Chemother 2002; 46: 3522-31.
65. Jin Y, Samaranayake LP, Samaranayake Y, Yip HK. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol 2004; 49: 789-98.
66. Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006; 55: 999-1008.
67. Heydorn A, Nielsen AT, Hentzer M et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 2000; 146: 2395-407.
68. da Silva WJ, Seneviratne J, Samaranayake LP, Del Bel Cury AA. Bioactivity and architecture of Candida albicans biofilms developed on poly(methyl methacrylate) resin surface. J Biomed Mater Res B Appl Biomater 2010; 94: 149-56.
69. Arnold JW, Bailey GW. Surface finishes on stainless steel reduce bacterial attachment and early biofilm formation: scanning electron and atomic force microscopy study. Poult Sci 2000; 79: 1839-45.
70. Williams DW, Kuriyama T, Silva S, Malic S, Lewis MA. Candida biofilms and oral candidosis: treatment and prevention. Periodontol 2000 2011; 55: 250-65.
71. Prasad R, Kapoor K. Multidrug resistance in yeast Candida. Int Rev Cytol 2005; 242: 215-48.
72. Chandra J, Zhou G, Ghannoum M. Fungal biofilms and antimycotics. Curr Drug Targets 2005; 6: 887-94.
73. Dovigo LN, Pavarina AC, Ribeiro AP et al. Investigation of the photodynamic effects of curcumin agains Candida albicans. Photochem Photobiol 2011b; 87: 895-903.
74. Sudjana AN, Carson CF, Carson KC, Riley TV, Hammer KA. Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil. Med Mycol 2012; 50: 863-70.
75. Konopka K, Goslinski T. Photodynamic therapy in dentistry. J Dent Res 2007; 86: 694-707.
76. Ramage G, Saville SP, Wickes BL, López-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002; 68: 5459-63.
77. Nett JE, Lepak AJ, Marchillo K, Andes DR. Time course global gene expression analysis of an in vivo Candida biofilm. J Infect Dis 2009; 200: 307-13.